These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3516587)

  • 1. A meta-analysis of the studies of dihydroergotamine plus heparin in the prophylaxis of deep vein thrombosis.
    Gent M; Roberts RS
    Chest; 1986 May; 89(5 Suppl):396S-400S. PubMed ID: 3516587
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylaxis for postoperative deep-vein thrombosis. Synergistic effect of heparin and dihydroergotamine.
    Kakkar VV; Stamatakis JD; Bentley PG; Lawrence D; de Haas HA; Ward VP
    JAMA; 1979 Jan; 241(1):39-42. PubMed ID: 758493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement.
    J Bone Joint Surg Am; 1989 Feb; 71(2):311-2. PubMed ID: 2918019
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of low-dose heparin and dihydroergotamine on frequency of postoperative deep-vein thrombosis in patients undergoing post-traumatic hip surgery.
    Lahnborg G
    Acta Chir Scand; 1980; 146(5):319-22. PubMed ID: 7468062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis.
    Sasahara AA; Koppenhagen K; Häring R; Welzel D; Wolf H
    Br J Surg; 1986 Sep; 73(9):697-700. PubMed ID: 3530367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroergotamine-heparin prophylaxis of postoperative deep vein thrombosis.
    JAMA; 1985 Feb; 253(5):636-7. PubMed ID: 3968800
    [No Abstract]   [Full Text] [Related]  

  • 7. Thromboembolic prophylaxis with dihydroergotamine-heparin in abdominal surgery. A controlled, randomized study.
    Pedersen B; Christiansen J
    Am J Surg; 1983 Jun; 145(6):788-90. PubMed ID: 6344677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydroergotamine-heparin prophylaxis of postoperative deep vein thrombosis. A multicenter trial. The Multicenter Trial Committee.
    JAMA; 1984 Jun; 251(22):2960-6. PubMed ID: 6371278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery.
    Lassen MR; Borris LC; Christiansen HM; Møller-Larsen F; Knudsen VE; Boris P; Nehen AM; de Carvalho A; Jurik AG; Nielsen BW
    Br J Surg; 1988 Jul; 75(7):686-9. PubMed ID: 2843255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis.
    Kakkar VV; Stringer MD; Hedges AR; Parker CJ; Welzel D; Ward VP; Sanderson RM; Cooper D; Kakkar S
    Am J Surg; 1989 Apr; 157(4):413-8. PubMed ID: 2539025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experience in orthopedics: routine surgery of the hip].
    Leyvraz HF
    Vasa Suppl; 1989; 27():171. PubMed ID: 2623496
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylactic efficacy of low-dose dihydroergotamine and heparin in postoperative deep venous thrombosis following intra-abdominal operations.
    J Vasc Surg; 1984 Sep; 1(5):608-16. PubMed ID: 6389909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of deep vein thrombosis in orthopedic surgery with the combination of low dose heparin plus either dihydroergotamine or dextran.
    Schöndorf TH; Weber U
    Scand J Haematol Suppl; 1980; 36():126-40. PubMed ID: 6161413
    [No Abstract]   [Full Text] [Related]  

  • 14. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine.
    Haas S; Stemberger A; Fritsche HM; Welzel D; Wolf H; Lechner F; Blümel G
    Arzneimittelforschung; 1987 Jul; 37(7):839-43. PubMed ID: 2823840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of dihydroergotamine and heparin in the prophylaxis of deep venous thrombosis.
    Comerota AJ; White JV
    Chest; 1986 May; 89(5 Suppl):389S-395S. PubMed ID: 3698718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial.
    Beisaw NE; Comerota AJ; Groth HE; Merli GJ; Weitz HH; Zimmerman RC; Diserio FJ; Sasahara AA
    J Bone Joint Surg Am; 1988 Jan; 70(1):2-10. PubMed ID: 3275673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of postoperative deep vein thrombosis by one daily injection of low molecular weight heparin and dihydroergotamine.
    Baumgartner A; Jacot N; Moser G; Krähenbühl B
    Vasa; 1989; 18(2):152-6. PubMed ID: 2545054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates of venous thrombosis after general surgery: combined results of randomised clinical trials.
    Colditz GA; Tuden RL; Oster G
    Lancet; 1986 Jul; 2(8499):143-6. PubMed ID: 2873407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should dihydroergotamine-heparin be used for prevention of postoperative thromboembolism?
    Emory CE; Cuddy PG
    Drug Intell Clin Pharm; 1987 May; 21(5):427-31. PubMed ID: 3107960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.